Gastrobody Therapeutics
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$1.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gastrobody Therapeutics is a biotechnology company developing ultrastable, orally-administered protein therapeutics to treat conditions of the gastrointestinal tract.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gastrobody Therapeutics Comparables
Compare Gastrobody Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plantibodies | 86% | |
| Sorriso Pharmaceuticals | 86% | |
| Fzata, Inc. | 80% |
Gastrobody Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$1.26M grant received from Technology Investment Fund and Wellcome Trust.
Gastrobody Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gastrobody Therapeutics's valuation, stock price, and market status.
Is Gastrobody Therapeutics a public or private company?
Gastrobody Therapeutics is a private company.
What is the current stock price of Gastrobody Therapeutics?
Gastrobody Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Gastrobody Therapeutics worth (valuation)?
Valuation information for Gastrobody Therapeutics is not publicly available.
Can I buy Gastrobody Therapeutics stock?
Gastrobody Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gastrobody Therapeutics's last funding round?
Gastrobody Therapeutics's most recent funding round was Grant on November 20, 2025.
Who are the main investors in Gastrobody Therapeutics?
Investor information for Gastrobody Therapeutics is not publicly disclosed.
Will Gastrobody Therapeutics IPO soon?
No public IPO plans have been announced for Gastrobody Therapeutics.
How can I track Gastrobody Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gastrobody Therapeutics's secondary market activity and sign up for updates.